Bernard Davitian
DirectoratLexeo Therapeutics· In proxies 2023–2024
Bernard Davitian sits on 5 public boards.
Boards1
- Lexeo TherapeuticsDirector · 3 yr on the boardIndependent—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Lexeo TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -69%
- Eyebiotech LimitedPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Upstream BioPublic company · 3 yr
- Director2021 – 2024 · 3 yrNo stock prices for these years
- Click TherapeuticsPublic company · 1 yr
- Director2018 – 2019 · 1 yrNo stock prices for these years
- Lyosomal TherapeuticsPublic company · 5 yr
- Director2014 – 2019 · 5 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?